{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:17:14Z","timestamp":1791685034401,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"am","delay-in-days":312,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015731","name":"Bayer Yakuhin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K16916"],"award-info":[{"award-number":["18K16916"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K16939"],"award-info":[{"award-number":["22K16939"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009031","name":"Japan Agency for Medical Research and Development Department of Industrial Academic Collaboration","doi-asserted-by":"publisher","award":["JP18lm0203010"],"award-info":[{"award-number":["JP18lm0203010"]}],"id":[{"id":"10.13039\/501100009031","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.exer.2022.109206","type":"journal-article","created":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T18:41:49Z","timestamp":1659292909000},"page":"109206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Analysis of the sustained release ability of bevacizumab-loaded tetra-PEG gel"],"prefix":"10.1016","volume":"223","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5421-8580","authenticated-orcid":false,"given":"Tomoya","family":"Murakami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1550-5821","authenticated-orcid":false,"given":"Sujin","family":"Hoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiki","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamasa","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6184-3835","authenticated-orcid":false,"given":"Takuya","family":"Katashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9071-7018","authenticated-orcid":false,"given":"Tetsuro","family":"Oshika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2022.109206_bib1","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1021\/ma302270a","article-title":"Transition between phantom and affine network model observed in polymer gels with controlled network structure","volume":"46","author":"Akagi","year":"2013","journal-title":"Macromolecules"},{"key":"10.1016\/j.exer.2022.109206_bib2","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1039\/c1py00034a","article-title":"FDA-approved poly(ethylene glycol)-protein conjugate drugs","volume":"2","author":"Alconcel","year":"2011","journal-title":"Polym. Chem."},{"key":"10.1016\/j.exer.2022.109206_bib3","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/01.iae.0000233327.68433.02","article-title":"Vitreous levels of unbound bevacizumab and unbound vascular endothelial growth factor in two patients","volume":"26","author":"Beer","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.exer.2022.109206_bib4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ophtha.2008.10.018","article-title":"Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the Anchor study","volume":"116","author":"Brown","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2022.109206_bib5","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ophtha.2010.02.021","article-title":"Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study","volume":"117","author":"Campochiaro","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2022.109206_bib6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijpharm.2006.06.012","article-title":"Solid lipid nanoparticles incorporated in dextran hydrogels: a new drug delivery system for oral formulations","volume":"325","author":"Casadei","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.exer.2022.109206_bib7","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1073\/pnas.71.8.3120","article-title":"Diffusion of polymer gel implants","volume":"71","author":"Davis","year":"1974","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.exer.2022.109206_bib8","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1001\/jamaophthalmol.2018.6776","article-title":"Effect of ranibizumab and aflibercept on best-corrected visual acuity in treat-and-extend for neovascular age-related macular degeneration: a randomized clinical trial","volume":"137","author":"Gillies","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.exer.2022.109206_bib9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/mabi.201400379","article-title":"Protein compatibility of selected cross-linking reactions for hydrogels","volume":"15","author":"Hammer","year":"2015","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.exer.2022.109206_bib10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41551-017-0044","article-title":"Fast-forming hydrogel with ultralow polymeric content as an artificial vitreous body","volume":"1","author":"Hayashi","year":"2017","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.exer.2022.109206_bib11","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ajo.2008.05.036","article-title":"Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans","volume":"146","author":"Krohne","year":"2008","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2022.109206_bib12","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ajo.2012.03.047","article-title":"Intraocular pharmacokinetics of ranibizumab following a single intravitreal injection in humans","volume":"154","author":"Krohne","year":"2012","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2022.109206_bib13","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1021\/ma100176f","article-title":"Evaluation of gelation kinetics of tetra-PEG gel","volume":"43","author":"Kurakazu","year":"2010","journal-title":"Macromolecules"},{"key":"10.1016\/j.exer.2022.109206_bib14","doi-asserted-by":"crossref","first-page":"9666","DOI":"10.1021\/ma201847v","article-title":"Connectivity and structural defects in model hydrogels: a combined proton NMR and Monte Carlo simulation Study","volume":"44","author":"Lange","year":"2011","journal-title":"Macromolecules"},{"key":"10.1016\/j.exer.2022.109206_bib15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/02713683.2018.1533983","article-title":"Biodegradable microsphere-hydrogel ocular drug delivery system for controlled and extended release of bioactive aflibercept in vitro","volume":"44","author":"Liu","year":"2019","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2022.109206_bib16","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.ophtha.2012.03.053","article-title":"Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results","volume":"119","author":"Martin","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2022.109206_bib17","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1021\/ma802280n","article-title":"Structure characterization of tetra-PEG gel by small-angle neutron scattering","volume":"42","author":"Matsunaga","year":"2009","journal-title":"Macromolecules"},{"key":"10.1016\/j.exer.2022.109206_bib18","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1021\/ma901013q","article-title":"SANS and SLS studies on tetra-arm PEG gels in as-prepared and swollen states","volume":"42","author":"Matsunaga","year":"2009","journal-title":"Macromolecules"},{"key":"10.1016\/j.exer.2022.109206_bib19","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ophtha.2011.01.031","article-title":"The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema","volume":"118","author":"Mitchell","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2022.109206_bib20","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00417-011-1649-1","article-title":"Pneumatic displacement of submacular hemorrhage with or without tissue plasminogen activator","volume":"249","author":"Mizutani","year":"2011","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2022.109206_bib21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1741-7015-8-76","article-title":"Topical insulin-like growth factor 1 treatment using gelatin hydrogels for glucocorticoid-resistant sudden sensorineural hearing loss: a prospective clinical trial","volume":"8","author":"Nakagawa","year":"2010","journal-title":"BMC Med."},{"key":"10.1016\/j.exer.2022.109206_bib22","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1021\/ma202386k","article-title":"Kinetic study for AB-type coupling reaction of tetra-arm polymers","volume":"45","author":"Nishi","year":"2012","journal-title":"Macromolecules"},{"key":"10.1016\/j.exer.2022.109206_bib23","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/mabi.201200384","article-title":"An anti-angiogenic reverse thermal gel as a drug-delivery system for age-related wet macular degeneration","volume":"13","author":"Park","year":"2013","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.exer.2022.109206_bib24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/MAO.0b013e3182009d29","article-title":"OTO-104: a sustained-release dexamethasone hydrogel for the treatment of otic disorders","volume":"32","author":"Piu","year":"2011","journal-title":"Otol. Neurotol."},{"key":"10.1016\/j.exer.2022.109206_bib25","series-title":"Retina: Medical and Surgical Management 531\u2013532","author":"Ravani","year":"2018"},{"key":"10.1016\/j.exer.2022.109206_bib26","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exer.2022.109206_bib27","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1021\/ma800476x","article-title":"Design and fabrication of a high-strength hydrogel with ideally homogeneous network structure from tetrahedron-like macromonomers","volume":"41","author":"Sakai","year":"2008","journal-title":"Macromolecules"},{"key":"10.1016\/j.exer.2022.109206_bib28","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1039\/c2sm07043j","article-title":"Effect of swelling and deswelling on the elasticity of polymer networks in the dilute to semi-dilute region","volume":"8","author":"Sakai","year":"2012","journal-title":"Soft Matter"},{"key":"10.1016\/j.exer.2022.109206_bib29","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1021\/acs.bioconjchem.5b00690","article-title":"Hydrogel drug delivery system using self-cleaving covalent linkers for once-a-week administration of exenatide","volume":"27","author":"Schneider","year":"2016","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.exer.2022.109206_bib30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1517\/17425247.2013.859135","article-title":"Drug delivery techniques for treating age-related macular degeneration","volume":"11","author":"Schwartz","year":"2014","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.exer.2022.109206_bib31","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1159\/000241896","article-title":"Dose-dependent sustained release of dexamethasone in inner ear cochlear fluids using a novel local delivery approach","volume":"14","author":"Wang","year":"2009","journal-title":"Audiol. Neuro. Otol."},{"key":"10.1016\/j.exer.2022.109206_bib32","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/lary.21370","article-title":"Principles of inner ear sustained release following intratympanic administration","volume":"121","author":"Wang","year":"2011","journal-title":"Laryngoscope"},{"key":"10.1016\/j.exer.2022.109206_bib33","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijbiomac.2013.05.034","article-title":"Sustained release of Avastin\u00ae from polysaccharides cross-linked hydrogels for ocular drug delivery","volume":"60","author":"Xu","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.exer.2022.109206_bib34","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1016\/S0142-9612(03)00337-5","article-title":"Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein","volume":"24","author":"Yamamoto","year":"2003","journal-title":"Biomaterials"}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448352200286X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448352200286X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:19:51Z","timestamp":1757999991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448352200286X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":34,"alternative-id":["S001448352200286X"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2022.109206","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of the sustained release ability of bevacizumab-loaded tetra-PEG gel","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2022.109206","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109206"}}